ALPMF News and Press, Astellas Pharma Inc From 01/12/26

2026-01-12 21:16:01 ET Astellas Pharma Inc. (ALPMY) 44th Annual J.P. Morgan Healthcare Conference January 12, 2026 6:00 PM EST... Read the full article on Seeking Alpha For further details see: Astellas Pharma Inc. (ALPMY) Presents at 44th Annual J.P. Morgan Healthcare Confe...

2026-01-02 15:00:31 ET More on the markets Realistic Expectations For 2026 Market Rotation Alert: Positioning For A Potentially Tumultuous Year S&P 500 And Bitcoin: After 4 Years Of Mediocrity From The Latter, I Own Both, Here's Why Steady start to 2026: ...

2025-12-17 07:23:49 ET More on Pfizer, Astellas Pharma ADR, etc. Pfizer Q4 2026 Financial Guidance Pfizer Inc. (PFE) Q4 2026 Guidance Call Transcript Pfizer: The Most Powerful Drug Pipeline In Pharma Could Deliver Major Long-Term Gains CDC signs off on change...

2025-12-12 10:38:34 ET Investment Overview - Apellis Stock Hits Painful Lows In First Half Of 2025 My last two ratings on Apellis Pharmaceuticals, Inc. ( APLS ), the Waltham, Massachusetts-based pharma company and complement system specialist, have been Holds, the first being in...

2025-12-10 10:26:49 ET Introduction AstraZeneca ( AZN ) is looking to be the first biopharma to throw off the cloak of cyclicality due to their work in optimizing the commercial and pipeline asset base. Despite being able to leverage experience and economies of scale, big pharma...

2025-12-05 16:48:55 ET The last time I spoke about Upstream Bio, Inc. ( UPB ) it was in a Seeking Alpha article entitled "Upstream Bio: Treating Respiratory Disorders With TSLP Targeting Differentiation." With respect to this article, I noted that the company was gearing up ...

2025-12-04 12:42:03 ET More on Taysha Gene Therapies Taysha Gene Therapies, Inc. (TSHA) Q3 2025 Earnings Call Transcript Taysha Gene Therapies: Breakthrough Rett Program With BLA Acceleration Potential Taysha Gene Therapies: Shares Are Soaring On FDA Alignment, But C...

2025-11-21 12:42:47 ET More on Merck Merck & Co., Inc. (MRK) Presents at Jefferies London Healthcare Conference 2025 Transcript Merck Has Many Bullish Attributes (Technical Analysis) Merck & Co., Inc. (MRK) M&A Call Transcript LLY joins $1T club b...

2025-10-31 17:28:43 ET The last time I spoke about Corbus Pharmaceuticals Holdings, Inc. ( CRBP ), it was in a Seeking Alpha article entitled "Corbus: Nectin-4 Targeting Proven With U.S. Data On The Way Early 2025." At that time, I spoke extensively about the development of ...

2025-10-31 16:10:22 ET More on Bicycle Therapeutics Bicycle Therapeutics: Looking For Their Niche, Addressing Cash Burn Bicycle Therapeutics Plc (BCYC) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript Seeking Alpha’s Quant Rating ...